Larimar Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.73

+0.23 (+5.11%)

As of Apr 1, 2:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +392.0% upside

Low Target $16.60

Average Target $23.27

High Target $30.48

Current Price $4.73

Current
$4.73

Target
$23.27

$16.60 $23.27 avg $30.48

Scenario Analysis

Bear Case

$16.60

251.0%

Low target

Base Case

$23.27

+392.0%

Avg target

Bull Case

$30.48

+544.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$6.42

-26.3% from high

52-Week Low

$1.61

+193.8% from low

Target vs 52W High

$23.27

+262.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%